ARTICLE | Company News
Eli Lilly, Sumitomo Dainippon deal
August 10, 2015 7:00 AM UTC
The companies partnered to co-promote Trulicity dulaglutide for Type II diabetes in Japan. The long-acting glucagon-like peptide-1 (GLP-1) receptor agonist is under review in the country. Sumitomo d...